MEREO BIOPHARMA GROUP PLC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $26.0M | $77.4M | $68.2M |
| FY2023 | $16.0M | $66.5M | $57.4M |
| FY2024 | $15.4M | $76.4M | $69.8M |
| FY2025 | $5.0M | $45.9M | $41.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $26.0M | $77.4M | $68.2M |
| FY2023 | $16.0M | $66.5M | $57.4M |
| FY2024 | $15.4M | $76.4M | $69.8M |
| FY2025 | $5.0M | $45.9M | $41.0M |